The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

Modell, 2017, Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement, Immunol Res, 65, 713, 10.1007/s12026-017-8907-1 Lankisch, 2015, The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?, J Clin Immunol, 35, 273, 10.1007/s10875-015-0149-1 Farmand, 2011, Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency [in German], Klin Padiatr, 223, 378 Arkwright, 2011, Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century, Ann N Y Acad Sci, 1238, 7, 10.1111/j.1749-6632.2011.06206.x Costa-Carvalho, 2014, Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice, J Clin Immunol, 34, 10, 10.1007/s10875-013-9954-6 Heimall, 2018, Use of genetic testing for primary immunodeficiency patients, J Clin Immunol, 38, 320, 10.1007/s10875-018-0489-8 Meyts, 2016, Exome and genome sequencing for inborn errors of immunity, J Allergy Clin Immunol, 138, 957, 10.1016/j.jaci.2016.08.003 King, 2018, Newborn screening for primary immunodeficiency diseases: history, current and future practice, J Clin Immunol, 38, 56, 10.1007/s10875-017-0455-x Kwan, 2015, History and current status of newborn screening for severe combined immunodeficiency, Semin Perinatol, 39, 194, 10.1053/j.semperi.2015.03.004 van der Spek, 2015, TREC based newborn screening for severe combined immunodeficiency disease: a systematic review, J Clin Immunol, 35, 416, 10.1007/s10875-015-0152-6 Modell, 2014, An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia, Immunol Res, 60, 145, 10.1007/s12026-014-8485-4 Picard, 2018, International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity, J Clin Immunol, 38, 96, 10.1007/s10875-017-0464-9 Bousfiha, 2018, The 2017 IUIS phenotypic classification for primary immunodeficiencies, J Clin Immunol, 38, 129, 10.1007/s10875-017-0465-8 Ammouch Maccari, 2018, Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry, Front Immunol, 9, 543, 10.3389/fimmu.2018.00543